chr5-132312263-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_003059.3(SLC22A4):āc.496A>Gā(p.Arg166Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000313 in 1,598,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R166T) has been classified as Uncertain significance.
Frequency
Consequence
NM_003059.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A4 | NM_003059.3 | c.496A>G | p.Arg166Gly | missense_variant, splice_region_variant | 2/10 | ENST00000200652.4 | |
MIR3936HG | NR_110997.1 | n.825-10T>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A4 | ENST00000200652.4 | c.496A>G | p.Arg166Gly | missense_variant, splice_region_variant | 2/10 | 1 | NM_003059.3 | P1 | |
MIR3936HG | ENST00000621103.4 | n.825-10T>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 1 | |||||
SLC22A4 | ENST00000491257.1 | n.300A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/4 | 4 | ||||
MIR3936HG | ENST00000669845.1 | n.451-10T>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251394Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135868
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1446256Hom.: 0 Cov.: 27 AF XY: 0.00000278 AC XY: 2AN XY: 720672
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.496A>G (p.R166G) alteration is located in exon 2 (coding exon 2) of the SLC22A4 gene. This alteration results from a A to G substitution at nucleotide position 496, causing the arginine (R) at amino acid position 166 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at